Namibia:Exchange Programme With Germany Partners to Assist With Cancer Battle
[Namibia Economist] The Cancer Association of Namibia (CAN) together with the Namibia National Cancer Registry have agreed to new collaborative engagements with their counter parts in Germany the, Krebsregister Rheinland-Pfal. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 17, 2018 Category: African Health Source Type: news

How to live longer: A handful of these nuts a day can slow down the ageing process
HOW TO live longer: Eating a healthy and balanced diet is one of the ways proven to increase life expectancy, but what exactly should you be eating? Nuts have been found to improve heart health and prevent serious conditions like type 2 diabetes and bowel cancer. So which ones should you be eating? (Source: Daily Express - Health)
Source: Daily Express - Health - October 17, 2018 Category: Consumer Health News Source Type: news

Targeted drugs for advanced cancer move from specialist units to community setting
Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network (NCCN) centres in the US, are receiving innovative drugs matched to DNA mutations in their tumours. This achievement, to be reported at the ESMO 2018 Congress in Munich,(1) shows that cutting-edge precision medicine is spreading from highly specialist cancer units to other healthcare facilities so more patients can benefit, wherever they are treated. (Source: World Pharma News)
Source: World Pharma News - October 17, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Bowel cancer: Eating THIS much red meat per day can increase the risk of bowel cancer
BOWEL cancer doesn ’t have any clear causes, but certain things can increase the risk of developing the disease, such as having a poor diet and eating too much red and processed meat. But how much red meat is too much? (Source: Daily Express - Health)
Source: Daily Express - Health - October 17, 2018 Category: Consumer Health News Source Type: news

Bowel cancer: Cut down on this type of meat to reduce the risk of bowel cancer symptoms
BOWEL cancer doesn ’t have any clear causes, but certain things can increase the risk of developing the disease, such as having a poor diet. Making simple diet changes can therefore help reduce the possibility of getting bowel cancer, such as cutting down on this type of meat. (Source: Daily Express - Health)
Source: Daily Express - Health - October 17, 2018 Category: Consumer Health News Source Type: news

DBT spots 34% more breast cancers than mammography
One-view digital breast tomosynthesis (DBT) detects 34% more breast cancers...Read more on AuntMinnie.comRelated Reading: Could DBT change the equation of screening younger women? DBT's benefits vary between Europe and the U.S. DBT again bests FFDM for screening DBT plus DM finds 90% more cancer than mammo alone DBT improves diagnostic mammography, too (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 17, 2018 Category: Radiology Source Type: news

Multiple Myeloma Concealed by Adrenal Cushing Syndrome Multiple Myeloma Concealed by Adrenal Cushing Syndrome
This unusual case of Cushing syndrome coexisting with multiple myeloma highlights the difficulty of both diagnosis and treatment of two diseases with overlapping symptoms.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Genome sequencing found feasible and informative for pediatric cancer treatment
(American Society of Human Genetics) Comprehensive genetic testing of tumors and non-cancerous tissue from pediatric cancer patients is a feasible and clinically useful approach that can guide patient care, according to findings presented at the American Society of Human Genetics (ASHG) 2018 Annual Meeting in San Diego, Calif. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

St. Jude investigators present novel pediatric cancer genome sequencing data at ASHG
(St. Jude Children's Research Hospital) Investigators from St. Jude Children's Research Hospital will present new findings at the American Society of Human Genetics annual meeting this week, including study results focused on the benefit of utilizing whole genome, exome and transcriptome sequencing for pediatric cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

A 150-year-old drug might improve radiation therapy for cancer
(Ohio State University Wexner Medical Center) A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy. Researchers found that the drug papaverine inhibits the respiration of mitochondria, the oxygen-consuming and energy-making components of cells, and sensitizes model tumors to radiation. They found that the drug does not affect the radiation sensitivity of well-oxygenated normal tissues. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 17, 2018 Category: International Medicine & Public Health Source Type: news

Combining genetic and sun exposure data improves skin cancer risk estimates
(American Society of Human Genetics) By combining data on individuals' lifetime sun exposure and their genetics, researchers can generate improved predictions of their risk of skin cancer, according to findings presented at the American Society of Human Genetics (ASHG) 2018 Annual Meeting in San Diego, Calif. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

Vast leukemia dataset could help researchers match therapies to patients
(Howard Hughes Medical Institute) Data on the molecular makeup and drug sensitivity of hundreds of patient samples could accelerate progress against the aggressive blood cancer acute myeloid leukemia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

OHSU-led effort results in largest cancer dataset of its kind
(Oregon Health& Science University) After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, 'Functional Genomic Landscape of Acute Myeloid Leukemia,' published today in Nature. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

ESMO Women for Oncology Forum focuses on power sharing to foster gender equality
(European Society for Medical Oncology) The Women for Oncology (W4O) Forum at ESMO 2018, Sharing the Power, on Friday October 19, will focus on power sharing between women and men working as a way of fostering gender equality in the oncology workforce. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

High-dose radiation therapy improves survival in patients once thought incurable
(American Society for Radiation Oncology) In the first randomized, phase II clinical trial of its kind, researchers have shown that an aggressive form of high-precision radiation therapy can greatly increase how long oligometastatic patients live and doubles how long they live without cancer. The findings will be presented in a news briefing and the plenary session at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO) next week. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

Five distinguished individuals to be honored with highest American Cancer Society Award
(American Cancer Society) The American Cancer Society will bestow its highest honor -- the Medal of Honor -- to five individuals during a celebration ceremony at the Ronald Reagan International Trade Center on Oct. 18 in Washington D.C. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

UC researcher fighting breast cancer with light therapy
(University of Cincinnati Academic Health Center) Nalinikanth Kotagiri, M.D., Ph.D., is studying ways ultraviolet light can activate light-sensitive drugs to treat metastatic breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

Charis Eng, M.D., Ph.D., receives prestigious Medal of Honor from American Cancer Society
(Cleveland Clinic) Charis Eng, M.D., Ph.D., chair of Cleveland Clinic's Genomic Medicine Institute, is receiving the American Cancer Society's Medal of Honor, the organization's highest award. An internationally recognized physician-scientist in the cancer genetics field, Dr. Eng is among five honorees to receive the award at a ceremony in Washington, D.C. on October 18. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

New method uses just a drop of blood to monitor lung cancer treatment
(Osaka University) Osaka University researchers have devised a simple method to measure the amount of cancer medication nivolumab that is bound to immune T-cells. The method requires just a drop of blood and can also measure the level of proliferation of those T-cells. The researchers show that these tests provide much more useful information for making treatment decisions than blood levels of the medication alone. Using these methods should also help reduce adverse reactions to therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

Sleeping beauty helps identify genes involved in a fatty liver-associated liver cancer
(Osaka University) Hepatocellular carcinoma, a deadly form of liver cancer, is increasingly being linked to non-alcoholic fatty liver disease; however, the underlying genetic mechanism of disease progression had remained unknown. Using a Sleeping Beauty mutagenesis screen, Osaka University researchers found that Sav1 and downstream components of the Hippo signaling pathway are drivers of the development of liver cancer associated with fatty liver disease. These findings pave the way for liver cancer treatments targeting the Hippo pathway. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions
(eLife) Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

Illinois scientists find stem cell proliferation is controlled directly by nervous system
(University of Illinois College of Agricultural, Consumer and Environmental Sciences) Somatic stem cells are microscopic workhorses, constantly regenerating cells throughout the body: skin and the lining of the intestine, for example. And to University of Illinois neuroscientists, they represent untapped potential. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

Cancer blood test trialed to prevent unnecessary chemotherapy
(Walter and Eliza Hall Institute) Cancer patients could be spared unnecessary chemotherapy -- and its side-effects -- by a new blood test that is in clinical trials at more than 40 hospitals in Australia and New Zealand. The trial is one of the largest trials internationally to investigate a predictive blood test to guide cancer treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

Liquid Biopsy May Reveal Treatment Response in Pediatric Brain Tumors Liquid Biopsy May Reveal Treatment Response in Pediatric Brain Tumors
In children with diffuse midline glioma (DMG), liquid biopsy based on analyses of circulating tumor DNA (ctDNA) in cerebral spinal fluid (CSF) or plasma shows promise for detecting mutational load and may serve as tool for assessing tumor response to treatment, researchers say.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 17, 2018 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Source: Judge Has Not Ordered A New Trial In $289.25M Monsanto Glyphosate Case
SAN FRANCISCO - A spokeswoman for the California state court judge presiding over the case of a cancer victim who won $289,254,882.32 in damages against Monsanto Co. related to exposure to glyphosate, the active ingredient in Monsanto's herbicide Roundup, on Oct. 11 said that contrary to published reports, the judge has not granted the company's motion for a new trial (DeWayne Johnson v. Monsanto Company, No. CGC 16550128, Calif. Super., San Francisco Co.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - October 17, 2018 Category: Medical Law Source Type: news

Monsanto, Cancer Victim File Proposed Orders On Possible New Glyphosate Trial
SAN FRANCISCO - The Monsanto Co. and the cancer victim who won $289,254,882.32 in damages against it related to exposure to glyphosate, the active ingredient in Monsanto's herbicide Roundup, on Oct. 12 filed proposed orders in California state court arguing their respective positions regarding whether the judge in the case should order a new trial (DeWayne Johnson v. Monsanto Company, No. CGC 16550128, Calif. Super., San Francisco Co.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - October 17, 2018 Category: Medical Law Source Type: news

Parties Debate Expedited Trial In Couple's Glyphosate Cancer Case Against Monsanto
OAKLAND, Calif. - A California state court judge, following arguments on Oct. 9, has set a hearing for November to consider more testimony regarding whether a couple who contends that glyphosate, the active ingredient in Monsanto Co.'s herbicide Roundup, has caused them both to develop cancer should be granted an expedited trial due to their deteriorating health, the couple's attorney said (Alva Pilliod v. Monsanto Company, No. RG17862702, Calif. Super., Alameda Co.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - October 17, 2018 Category: Medical Law Source Type: news

QBI pioneers a collaborative and inclusive approach to scientific discovery
UCSF ’s Quantitative Biosciences Institute (QBI), founded two years ago, is making waves with its unique approach to scientific collaboration, catalyzing discoveries from cancer to psychiatry while supporting female scientists and engaging with the public. (Source: UCSF School of Pharmacy News)
Source: UCSF School of Pharmacy News - October 17, 2018 Category: Universities & Medical Training Authors: Levi Gadye Source Type: news

Bigger Family, Lower Cancer Risk?
Researchers who analyzed data from 178 countries found that people from larger families were less likely to get cancer than those from smaller families. (Source: WebMD Health)
Source: WebMD Health - October 16, 2018 Category: Consumer Health News Source Type: news

FDA Approves Talzenna (talazoparib) for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer
On October 16, 2018, the Food and Drug Administration approved talazoparib (Talzenna, Pfizer Inc.), a poly (ADP-ribose) polymerase (PARP) inhibitor, for patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm),... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 16, 2018 Category: Drugs & Pharmacology Source Type: news

How Do We Produce the Best Outcomes in Rare Thymic Neuroendocrine Tumors?
A retrospective analysis found that surgical resection and radiotherapy are linked to superior outcomes in patients with thymic neuroendocrine tumors. (Source: CancerNetwork)
Source: CancerNetwork - October 16, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Significance of MHC-II in Immunotherapy
While previous research has proven the role of MHC-I molecules, a new study inCell suggests that MHC-II may also serve as a target in immunotherapy. (Source: CancerNetwork)
Source: CancerNetwork - October 16, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news

Age, Lymph Node Positivity Link in Thyroid Cancer
A new study inCancer Management and Research found a correlation between the age of patients with papillary thyroid cancer and lymph node positivity. (Source: CancerNetwork)
Source: CancerNetwork - October 16, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Does Frailty Predict for Complications After Bladder Cancer Surgery?
Measures of frailty and comorbidity failed to offer predictive information regarding complications in patients with bladder cancer undergoing radical cystectomy. (Source: CancerNetwork)
Source: CancerNetwork - October 16, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

How healthy will YOUR country be in 2040?
Researchers from Washington University have predicted the average lifespans of countries around the world and predict more people will die of non-contagious diseases like cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - October 16, 2018 Category: Consumer Health News Source Type: news

Low PNI Predicts Poor Liver Cancer Outcomes
(MedPage Today) -- Meta-analysis supports prognostic tool for hepatocellular carcinoma (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 16, 2018 Category: Gastroenterology Source Type: news

Spain to beat Japan in world life expectancy league table for 2040
Mediterranean lifestyle takes effect in Spain but US continues to drop down tablePeople in Spain are predicted to have the longest life expectancy in the world by 2040 – beating Japan into second place – and much of the reason is to do with the way they eat, according to the authors of the most comprehensive study of the global burden of disease.In the years to come, the biggest threats to our health and longevity will be obesity, high blood pressure and blood sugar, tobacco use and drinking alcohol, according to the Institute for Health Metrics and Evaluation in Seattle, US, which has produced the forecasts.Co...
Source: Guardian Unlimited Science - October 16, 2018 Category: Science Authors: Sarah Boseley Health editor Tags: Spain Ageing US news Smoking Cancer Heart disease Health UK news World news Japan Science Source Type: news

Urine Exosome Assay Could Curb Unnecessary Prostate Biopsies Urine Exosome Assay Could Curb Unnecessary Prostate Biopsies
Exosome Diagnostics'ExoDx Prostate (IntelliScore) (EPI) urine exosome gene expression assay may help avoid unnecessary prostate biopsies, according to a large prospective study.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 16, 2018 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Confirmed AGAIN: Sodium nitrite preservative in processed meat causes breast cancer
(Natural News) The jury is in and the verdict is final: Processed meats like bacon, salami and sausage all increase breast cancer risk. A metanalysis of all 15 previously conducted studies on the subject, published recently in the International Journal of Cancer, has confirmed that eating processed meat is associated with a 9 percent increase... (Source: NaturalNews.com)
Source: NaturalNews.com - October 16, 2018 Category: Consumer Health News Source Type: news

Latest Pancreatic Cancer Staging System & quot;Slightly & quot; More Prognostic Latest Pancreatic Cancer Staging System & quot;Slightly & quot; More Prognostic
Compared to the previous edition, the recently released eighth edition of the TNM staging system shows a modest increase in prognostic accuracy for patients with resected pancreatic ductal cancer, researchers say.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - October 16, 2018 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Selumetinib: No Benefit Boosting RAI for High Risk Thyroid Cancer Selumetinib: No Benefit Boosting RAI for High Risk Thyroid Cancer
Though previous research showed the MEK1/2 inhibitor could improve RAI effect, the phase 3 trial failed to reach its primary endpoint.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 16, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Nerve Plane Block May Improve Mastectomy Pain
(MedPage Today) -- Also: obese children and post-surgery pain; patient-controlled epidurals after C-section (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 16, 2018 Category: Hematology Source Type: news

FDA Approves Talazoparib in BRCA+ Breast Cancer FDA Approves Talazoparib in BRCA+ Breast Cancer
Compared with standard chemotherapy, the PARP inhibitor extended progression-free survival for patients with advanced BCRA-positive breast cancer.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 16, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

FDA approves Pfizer advanced breast cancer med
The drug is part of a class of new medicines called PARP inhibitors, which block enzymes involved in repairing damaged DNA (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 16, 2018 Category: Pharmaceuticals Source Type: news

Positive HPV Status Tied to Better Cervical Cancer Prognosis
TUESDAY, Oct. 16, 2018 -- Women with high-risk human papillomavirus (hrHPV)-positive cervical tumors have a substantially better prognosis than women with hrHPV-negative tumors, according to a study published online Oct. 1 in PLOS Medicine. Jiayao... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2018 Category: Pharmaceuticals Source Type: news

Immune Design lays off workers and shifts course after halting lead cancer vaccine trial
The layoffs amount to about 20 percent of Immune Design's workforce in Seattle and San Francisco. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 16, 2018 Category: Biotechnology Authors: Casey Coombs Source Type: news

New sensor helps prevent skin cancer by changing color when you’ve had too much sun, fits on a thumbnail
(Natural News) Heliophiles are in for a treat. UV Sense, a recently launched sensor, can alert users when they’ve had too much exposure. UV Sense is a battery-free device that can fit on a thumbnail, and it was designed to detect radiation from the sun. The sensor can change color to indicate the radiation levels of... (Source: NaturalNews.com)
Source: NaturalNews.com - October 16, 2018 Category: Consumer Health News Source Type: news

Cancer for Christmas: All those tech gadgets raise your (and your child’s) risk of cancer, according to health officials
(Natural News) Getting the latest phone or smart toy this holiday season may not be all that good of a gift for you or your children, experts believe. In a discussion held about the risk of cell phones and high-tech toys and its preventive measures, health and technology experts, including Dr. Ronald Melnick, a former... (Source: NaturalNews.com)
Source: NaturalNews.com - October 16, 2018 Category: Consumer Health News Source Type: news

Paul Allen ’s death shines light on non-Hodgkin lymphoma
The co-founder of Microsoft died Monday from complications with the disease, which is one of the most common cancers in the United States (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 16, 2018 Category: Consumer Health News Source Type: news

Fish oil may curb breast cancer cells growth, spread
A diet containing omega-3 fatty acids found in fish oil may help control the growth and spread of breast cancer cells, according to a study with mice. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 16, 2018 Category: Consumer Health News Source Type: news